News

AddToAny

Google+ Facebook Twitter Twitter

Mapping the entire human gut at single cell resolution

For the first time, entire human GI tracts from three organ donors have been used to show how cell types differ across all regions of the intestines.

Scientists from the University of North Carolina hope their work will shed light on cellular functions and show gene expression differences between these cells and individuals.

The work opens the door to exploring the many facets of gut health in a much more precise manner at greater resolution than ever before.

Research lead Scott Magness said: “Our lab showed it’s possible to learn about each cell type’s function in important processes, such as nutrient absorption, protection from parasites, and the production of mucus and hormones that regulate eating behaviour and gut motility.

“We also learned how the gut lining might interact with the environment through receptors and sensors and how drugs could interact with different cell types.”

bit.ly/3t0ZMfC

Image credit | Magness Lab UNC School Of Medicine

Related Articles

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Blue helix human DNA structure-Image credit-shutterstock-1669326868

The search for genes that cause diseases

A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease.

pathogenspreadhr-CREDIT-spooky-pooka

Figuring out the threats: Problem-solving with genomics

As the COVID-19 enquiry continues to unpick the tangled threads of the pandemic response, little has been said about one of the most effective weapons against the SARS-Cov-2 virus – pathogen genomics.

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Top